Gf Fund Management Co. Ltd. Axsome Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,241 shares of AXSM stock, worth $124,956. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,241
Previous 1,018
21.91%
Holding current value
$124,956
Previous $86.1 Million
68.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
409Shares Held
36.6MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$390 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$332 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$294 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$170 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98.3 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.32B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...